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ABSTRACT 
 
Introduction: Ameloblastomas are locally aggressive with a high recurrence rate, warranting 
continuity jaw resection.  The preservation of the inferior alveolar nerve during ablative 
surgery in the treatment of ameloblastoma is contentious.  Studies have suggested salvaging 
the nerve by pulling it out of the tumour prior to resection.  There are presently no studies 
that have explored the surgical merit of nerve preservation in the treatment of 
ameloblastomas. 
Aim: To determine the histological association of mandibular solid and multicystic 
ameloblastoma to the inferior alveolar nerve, in situ and in separately removed segments of 
the nerve in order to determine the feasibility of preserving the nerve during ablative surgery 
for mandibular ameloblastomas.   
Materials and Methods: 13 resected hemimandibulectomy specimens were histologically 
examined with respect to the course and association of the inferior alveolar canal/nerve and 
the ameloblastoma.  In group 1 (8 patients) this association was examined with the nerve 
within the mandibular segment following resection whilst in group 2 (5 patients) the nerve 
was explanted from the resected tumour and examined separately.  In group 1 the closest 
histologic distance between tumour cells and the inferior alveolar canal was measured. 
Results: Perineural and intraneural ameloblastoma involvement of the inferior alveolar nerve 
was confirmed in 62.5% and 40% of cases in groups 1 and 2 respectively.  Tumour cells 
were noted abutting directly onto the nerve in Group 1.  Tumour cells were removed 
together with the pulled out nerve in Group 2.  There was no correlation between the 
histological variants of ameloblastoma and the presence of tumour either in situ or within the 
pulled-out nerve bundle.   
vi 
 
 
 
Conclusion: Both peri- and intraneural involvement of the inferior alveolar nerve was 
histologically confirmed in solid and multicystic hemimandibular specimens both in situ 
within the tumour as well as in separately removed segments of the nerve.  Preservation of 
the inferior alveolar nerve during ablative surgery for mandibular ameloblastomas cannot be 
advocated. 
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PREFACE 
 
The ameloblastoma is the most commonly treated benign odontogenic tumour.  The 
treatment and subsequent reconstruction of the defect has been extensively researched and 
debated, with several treatment modalities available to the surgeon. 
 
Of late, several authorities have suggested that the inferior alveolar nerve be spared during 
ablative surgery, by pulling the nerve out from the tumour and anastomosing the cut ends, a 
procedure which results in a high rate of sensory recovery.  There have been no studies, 
however, commenting on the recurrence rate of the tumour in patients having had such 
surgery in comparison to patients where the nerve had been sacrificed. 
 
There have been no studies examining the inferior alveolar nerve histologically when the 
nerve has been spared by pulling it out from the tumour or when the nerve has been removed 
together with the tumour in order to determine the viability of the different techniques.  This 
study is thus highly relevant as the anticipated findings will aid the surgeon in treatment 
planning for mandibular ameloblastomas. 
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
The ameloblastoma is the most commonly occurring and treated benign tumour in the head 
and neck area.  It may reach grotesque sizes, leading to debilitating deformity and loss of 
function.  The treatment and subsequent reconstruction of the defect has been extensively 
researched, debated and published with several accepted treatment modalities available to the 
surgeon.
1-4
  In certain types of ameloblastoma, complete excision with a 1cm safety margin is 
the accepted standard of care, with reconstruction of the bony framework and soft tissue 
aimed at restoring masticatory function, speech and appearance.
4 
 
With regard to the restoration of neurosensory function following ablative surgery, several 
authorities
5-7
 have recently advocated the sparing of the inferior alveolar nerve by pulling the 
nerve out from the tumour.  As the tumour is benign in nature, it is postulated that the inferior 
alveolar nerve bundle would be free of tumour if removed from the affected mandible, and 
thus should not increase the patient’s chance of developing a recurrent tumour.5 
   
Ameloblastomas are known to be locally aggressive and destructive, with a high rate of 
recurrence if not treated aggressively.  To the best of our knowledge there are presently no 
studies that have assessed the recurrence rate of the tumour in patients who have had surgical 
removal of the tumour with preservation of the inferior alveolar nerve, in comparison to 
patients where the nerve was sacrificed with removal of the tumour.   
  
2 
 
 
 
Furthermore, no studies have examined the inferior alveolar nerve bundle histologically 
following either procedure.  Thus the need for a histologic study in which the association of 
ameloblastoma in relation to the inferior alveolar nerve is assessed both when removed with 
the tumour and when removed separately.  The findings of such an investigation will be 
useful in guiding the management of the inferior alveolar nerve during ablative surgery for 
mandibular ameloblastoma.  
 
 
 
 
 
 
 
 
 
 
  
3 
 
 
 
CHAPTER 2 
 
2.0 LITERATURE REVIEW 
 
2.1 The ameloblastoma 
The most common benign tumour affecting the jaws is the ameloblastoma.
1-3
  It is a tumour 
of odontogenic epithelial origin, that exhibits locally aggressive behaviour.
1-4
  The mandible 
is involved 7 to 8 times more frequently than the maxilla.
1
  The angle, ascending ramus and 
body are most commonly affected in the mandible.
1,2,8 
 Benign ameloblastomas are classified 
into 3 main groups, namely the solid and multicystic, unicystic and peripheral variants.
3 
 The 
distinction between the different clinicopathologic subtypes is important as the biological 
behaviour, treatment and prognosis may differ for each variant.
3,4,9-12
   
 
Ameloblastomas can reach grotesque sizes, causing a substantial amount of local destruction 
and severe deformity (Figs. 2.1 and 2.2).  In general though, they are not known to be 
infiltrative
11-14
 and very seldom undergo malignant change or metastasize.
3,4
  
 
Multiple histological subtypes of ameloblastoma have been described,
1-3 
 and some authors 
suggest that the histological subtype should guide the surgeon in treatment planning.
8,11 
 Their 
contention is that certain histological subtypes tend to exhibit less aggressive behaviour than 
others.
2,11 
 Other authors
1,2
 have noted that larger ameloblastomas generally have a mixed 
histological pattern rendering the notion that histological subtype could guide treatment 
planning invalid.  
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Fig. 2.1 Patient exhibiting gross deformity caused by a mandibular solid and multicystic ameloblastoma 
 
 
Fig. 2.2 Panoramic radiographic view of the patient above (Fig 2.1) demonstrating obliteration/loss of the 
course of the inferior alveolar canal on the left side 
5 
 
 
 
It is well known and widely published that ameloblastomas in spite of being benign in nature, 
have a high recurrence rate if appropriate primary treatment is not instituted timeously.
1,2,4
  
Recurrence rates of 1% to 15% have been recorded following radical treatment, especially 
following resection with a safety margin,
15 
and up to 90% following conservative 
management such as enucleation and marsupialisation.
15,16 
 
Increased recurrence rates have been linked to specific histological subtypes of 
ameloblastomas, specifically the follicular, granular and acanthomatous types.
8  
The 
desmoplastic type has been found to be less aggressive with a lower recurrence rate.
3 
 
2.2 Current treatment modalities 
Various treatment modalities for ameloblastomas have been described and these range from 
conservative therapies such as decompression with marsupialisation and enucleation,
11
 to the 
more radical approach which includes a large continuity resection.
1,2,4 
 Furthermore, the 
treatment options for each clinical variant of ameloblastoma differs; ranging from excision 
for the peripheral variant, enucleation with adjunctive therapy for luminal and intraluminal 
unicystic ameloblastomas and resection with clear margins for the mural unicystic and the 
solid and multicystic ameloblastomas.
1-4
  The various recommendations on the extent of the 
resection
4,9-12
 range from resection with a 1 to 2 cm margin in bone
4,17,18
 to a more 
conservative en-bloc resection with preservation of the lower border of the mandible.
10
   
 
In addition, different treatment protocols for each histological subtype have also been 
suggested, such as an aggressive resection for follicular subtypes and resection with a smaller 
margin for plexiform or desmoplastic variants.
3,11
    However, the treatment protocol requires 
6 
 
 
 
correlation of the clinical and radiographic appearance, the operative findings and the 
histological subtype of the tumour.
1-4,9-12 
 
 
Recent consensus is that a more aggressive approach is warranted for the treatment of the 
solid and multicystic ameloblastoma due to the extremely high recurrence rate following 
conservative treatment.
3,4,8-10,13,19   
Some authors believe that the only exception to such 
treatment would be in children, where a more conservative approach is advocated.
20
  
 
Aggressive surgical removal of the tumour more often than not leads to ablative surgery 
resulting in continuity defects of the mandible.  These defects may cause great functional, 
aesthetic and emotional debilitation.  Following the impairment of the initial surgery, the 
reconstruction of the patient has been widely debated and published.
9-12,19
  Surgeons concur 
that the patient be restored as closely as possible to pre-treatment function and aesthetics.  
Options for reconstruction of the patient after tumour resection include vascularised tissue 
transfer, most notably of the fibula;
19 
free block grafts commonly taken from iliac crest;
3,7
 
particulate cortico-cancellous bone and marrow grafts also taken from iliac crest
3,4
 and 
recently distraction osteogenesis.
21
  These procedures aim to create a bony and soft tissue 
base upon which further dental rehabilitation can be done, by means of implant placement 
into the graft (either immediate or delayed) and placement of a fixed or removable 
prosthesis
19,22 
as demonstrated in Fig. 2.3.  The eventual outcome must be a patient that has 
been rehabilitated functionally and cosmetically. 
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Fig. 2.3 Panoramic radiograph demonstrating a cortico-cancellous bone graft and implant placement for dental 
rehabilitation following an angle to angle resection of the mandible for treatment of a solid and multicystic 
ameloblastoma  
 
Alternative and adjuvant therapies, including radiotherapy and chemotherapy have been 
found to have little effect on the tumour.
1,23-25 
 It has also been reported in a canine model that 
radiation can induce malignant transformation of the ameloblastoma.
24 
 In the latter study 
ameloblastomas were induced in canine subjects and subsequently treated with radiation.  
The detrimental effects of the radiation that may evoke radiation-induced malignancy also 
extend to the surrounding tissue and structures, as the tumours are generally located within 
bone.
1
  This treatment modality is thus reserved for extreme cases that are irresectable and 
life threatening,
1
 such as extensive maxillary ameloblastomas that encroach on the skull base 
and which cannot be surgically removed. 
 
New treatment modalities obviating the need for surgery in the treatment of ameloblastoma 
are currently being researched.  These treatment modalities are aimed at the molecular basis 
of tumour origin and may take the form of agents being delivered locally (directly into the 
8 
 
 
 
tumour), a process that will target specific signalling pathways.
26 
 Despite the myriad of 
treatment options suggested the consensus remains that aggressive treatment provides the 
best prognosis for solid and multicystic ameloblastomas.
1,2,4,8
 
 
2.3 The inferior alveolar nerve 
The inferior alveolar nerve is the main sensory nerve to the mandible, supplying the oral 
mucosa, the dentition and the skin overlying the chin and the lower lip.  The third division of 
the trigeminal nerve exits the base of skull via the foramen ovale, after which it splits into an 
anterior and posterior trunk.  The inferior alveolar nerve arises within the posterior trunk and 
then passes through the mandibular foramen into the mandibular canal on the medial side of 
the ramus of the mandible.  It traverses the canal and exits at the mental foramen.
27-29
   
 
The nerve consists of myelinated axons that make up nerve fibres.  These fibres are encased 
in a thin connective tissue layer called the endoneurium.  A group of fibres coupled together 
and encased by another layer of connective tissue, or perineurium, is called a fascicle.  A 
couple of fascicles arranged together and surrounded by connective tissue, called epineurium, 
make up a nerve bundle (Fig. 2.4).
29 
 
Expanding tumours, cysts and other lesions of the mandible have been reported to involve the 
inferior alveolar canal.
4,11,12
  This may include circumferential involvement and or destruction 
of the inferior alveolar canal, often with displacement of the canal away from its normal 
position.
30
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Nerve involvement by the tumour may lead to altered sensation (either hypoaesthesia or 
uncommonly hyperaesthesia), in the area of its distribution.
 
 As the inferior alveolar nerve 
runs within the bone in the ramus, angle and body of the mandible, it is commonly resected 
together with the tumour.  The resulting loss of nerve sensation although most often benign 
may also lead to drooling, speech impediment, unintentional lip biting, residual food 
stagnation on the lip, burning pain, tingling and scalding of the lip with hot subtances.
5,27
  
This may be quite injurious in some patients.  Preservation of the neurovascular bundle 
during ablative surgery to treat ameloblastoma in order to prevent the many resultant signs 
and symptoms of neural fallout is thus an extremely important consideration. 
Fig. 2.4 Schematic illustration of a nerve: The brown outer layer is the epineurium, a connective 
tissue sheath surrounding the entire nerve.  The red sheaths indicate the perineurium that encloses 
bundles of nerve fibres. The blue sheaths represent the delicate endoneurium that surrounds 
individual nerve fibres (green) 
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2.4 Management of the inferior alveolar nerve during ablative surgery 
Great debate exists amongst maxillofacial and oral surgeons regarding preservation of the 
inferior alveolar neurovascular bundle during ablative surgery in the treatment of 
ameloblastomas.
5-7,11,12,14,30   
Becker
7
 first described preservation of the inferior alveolar 
neurovascular bundle during ablative surgery, but suggested that this technique not be used 
for the treatment of the solid and multicystic ameloblastoma.   
 
Becker’s technique7 entailed sectioning of the mandible, with segmental removal of the 
tumour surrounding the nerve, preserving the nerve bundle in its entirety (Figs. 2.5 to 2.7).  
Subsequent to the piece-meal removal of the tumour from around the nerve, the defect is 
restored with a block graft from the iliac crest.  A groove is prepared centrally within the 
graft to mimic the inferior alveolar canal and the nerve is placed within the graft.  The graft is 
secured by using either wire or plates. 
  
Becker
7
 recommended that the technique be used for benign cystic lesions such as cystic 
ameloblastomas and dentigerous cysts, as well as other benign pathology including 
osteomyelitis of the mandible.  However, he expressed concern for the use of this technique 
in solid and multicystic ameloblastomas in view of the possible seeding of tumour into 
surrounding soft tissue.
 
 In spite of the neurovascular bundle being left intact, some 
permanent sensory fall-out in a small area of the lower lip was reported.
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Fig. 2.5 Diagrammatic illustration of displacement of the inferior alveolar canal (brown) by a 
solid and multicystic ameloblastoma (red) of the left mandibular angle and body 
 
Fig. 2.6 Diagrammatic illustration of the particulate removal of the tumour, sparing the nerve in 
its entirety 
 
Fig. 2.7 Diagrammatic sketch showing the iliac crest block graft secured to the mandible and  
spanning the defect.  The nerve lies centrally within the fabricated groove. 
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Ishikawa et al.
5
 proposed an alternative technique (Figs. 2.8 to 2.11) whereby the nerve is 
severed together with one of the resection margins and pulled through the mandibular and 
mental foramina.  The nerve endings are subsequently anastomosed microsurgically. 
  
 
Fig 2.8 Diagrammatic illustration of the displacement of the inferior alveolar canal (brown) of a solid and 
multicystic ameloblastoma (red) of  the left  mandibular angle and body 
 
 
Fig. 2.9 Diagrammatic illustration of the Ishikawa et al.
5
 technique.  The mandible is sectioned anterior to the 
tumour margin and the nerve is cut (green lines).  The proximal segment is reflected   open (black arrow) and 
the nerve is pulled out of the mandible with a hook, via the mandibular  foramen at the lingula 
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Fig. 2.10 Diagrammatic sketch showing the anastomosis of the cut inferior alveolar nerve ends after resection of 
the ameloblastoma 
 
Fig. 2.11 Diagrammatic illustration showing interim reconstruction of the defect using a  reconstruction plate 
(blue); note the nerve anastomosis (green) 
The following criteria for the use of this technique were recommended by Ishikawa et al.
5
 
 There should be no pre-operative loss of sensation in the area of distribution of the 
inferior alveolar nerve 
 The nerve must be pulled through with ease, showing no signs of pathologic 
adhesion 
 The nerve trunk should exhibit normal elasticity 
 The neural sheath should appear smooth, glossy, uniform and regular 
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A case of resection of a solid and multicystic ameloblastoma following Becker’s technique7 
coupled with the simultaneous placement of a bone graft was published by Wu et al.
6 
in 1984.  
The patient showed good sensory recovery and had no recurrence at the time of publication 
(after 2 years). 
 
The sensory recovery of the inferior alveolar nerve following multiple insults during ablative 
surgery, including sectioning, tension on the nerve to remove it and anastomosis has not been 
formally described.  However, there are numerous reports in the literature regarding 
trigeminal nerve recovery following surgical intervention to restore function, where nerve 
ends were anastomosed following trauma, or partial resection with anastomosis was done for 
paraesthesia.  In these reports recovery approached levels of well above 75%.
31,32
  From this 
we can deduce that the nerve will recover well following Ishikawa’s technique.5  This would 
have a great impact on relieving morbidity post-operatively. 
 
Zehm et al.
33
 examined the nerve and its relation to the tumour and found tumour cells to be 
in close proximity to the epineurium, although it did not penetrate deeper than the 
epineurium.  Pourian et al.
14
 also examined and measured the distance between the 
neurovascular bundle (epineurium) and the closest ameloblastoma tumour cells and found 
this to be 120µm.  The latter report stressed that the tumour cells were too close to the 
neurovascular bundle to consider pulling out the nerve, resulting in tumour cells being 
removed together with the nerve leading to eventual recurrence. 
 
Based on the findings of Zehm et al.,
33
 Tung-Yiu et al.
34
 reported a case where an epineural 
dissection of the inferior alveolar nerve was performed at the time of resection of a plexiform 
ameloblastoma affecting the mandibular angle.  The patient had an immediate reconstruction 
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of the defect utilising a block graft from the iliac crest.  The dissected nerve was placed next 
to the block graft and covered by mucosa.  Sensory recovery was acceptable, with a good 
two-point discrimination test and only mild paraesthesia subjectively reported by the patient.  
 
Alternatives to saving the inferior alveolar nerve during resection and aimed at restoration of 
sensation to the lower lip have been described.
35-37
  Reconstruction by means of autogenous 
grafting with local or distant nerves has been advocated, most commonly the great auricular 
nerve,
35 
the sural nerve
36
 and the long thoracic nerve.
37
  The nerves are harvested and 
anastomosed to the cut ends of the inferior alveolar nerve.  This is ideally done at the time of 
the initial resection, as atrophy and fibrosis of the surgical bed creates surgical problems if 
grafting is performed secondarily.  The rate of recovery is variable, ranging from good patient 
satisfaction rates to continued paraesthesia.  Donor site morbidity remains a worry too, as the 
donor site skin may show paraesthesia or complete anaesthesia.  Unnecessary scarring of the 
patient is also a concern. 
 
Chou et al.
28
 reported that no attempt at reinstating sensation should be considered as the 
patients in their study group all had favourable outcomes with regard to sensory recovery and 
acceptance.  They noted some adaptation to the fall-out, generally in the form of sensory 
perception to touch.
28
  Some patients even displayed signs of neurosensory recovery in the 
affected area, most likely due to collateral sprouting of surrounding nerves.  This 
phenomenon has been widely described and can result in complete sensory recovery in 
children.
38
  It should be noted that the patients in the study by Chou et al.
28
 were generally 
younger patients. 
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Nakamura
 
et al.
11
 and others
5
 suggested that the pull-through technique with end-to-end 
anastomosis of the inferior alveolar nerve be used only for unicystic ameloblastomas and 
certain sub-types of solid and multicystic ameloblastomas such as the plexiform variant.  
They found no perineural infiltration in their evaluation of the proximity of all types of 
ameloblastic tumour cells to the mandibular neurovascular bundle, but found that the 
follicular pattern of ameloblastoma in particular showed tumour cells in direct apposition to 
the nerve sheath.  Nakamura et al.
11
 postulated that the nerve, if pulled through, would be 
tumour free.  Follow-up studies revealed that apposition of ameloblastomatous cells to the 
nerve sheath was not restricted to the follicular pattern specifically, but rather correlated to 
the size of the tumour.
9
  
 
The preservation of the inferior alveolar neurovascular bundle during ablative surgery in the 
treatment of ameloblastoma is contentious.  In the absence of the great risk for recurrence of 
the lesion, preserving the nerve during resection would be the treatment modality of choice.  
Many studies report on the recurrence rates of ameloblastomas,
3,4,9-11
 there are however 
unfortunately no studies which review and compare the recurrence rate in patients following 
treatment of ameloblastomas with and without preservation of the nerve.   
 
The possibility of recurrence is undoubtedly the biggest cause for concern when considering 
preservation of the inferior alveolar nerve during ablative surgery.  There is thus a very clear 
need to establish histologically whether a preserved nerve will be free of tumour cells.  
 
Currently there are no South African or global studies that have histologically examined the 
association of ameloblastoma tumour cells to the inferior alveolar nerve following surgical 
removal of the nerve from the tumour.  Furthermore there are no studies that have explored 
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the possibility of preserving the inferior alveolar nerve during segmental resection of the 
mandible, with adequate follow-up to evaluate possible recurrence rates.  Only studies that 
have measured the distance between tumour cells and the nerve with the neurovascular 
bundle left in situ have been reported.
11,30,33
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CHAPTER 3 
 
3.0 AIM AND OBJECTIVES 
 
3.1 Aim 
The aim of this study was to determine the histological association of the solid and 
multicystic  ameloblastoma in hemimandibular specimens to the inferior alveolar nerve, both 
in situ within the tumour as well as in separately removed segments of the nerve in order to 
determine the feasibility of preserving the inferior alveolar nerve during ablative surgery for 
mandibular ameloblastomas.   
 
3.2 Objectives 
This will be achieved by a histological measurement of the distance between the  
ameloblastomatous tumour cells and the epineurium of the inferior alveolar nerve, as well  
as determining whether tumour cells are removed together with the pulled out nerve. 
 
3.3 Comment 
The findings of the study will guide the surgical treatment protocol for patients with 
mandibular ameloblastomas, especially with regards to preservation or removal of the inferior 
alveolar nerve.  This is a highly relevant study as there are currently no treatment guidelines 
pertaining specifically to the management of the inferior alveolar nerve during ablative 
surgery for mandibular ameloblastomas. 
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CHAPTER 4 
 
4.0 MATERIALS AND METHODS 
 
4.1 Study design 
A prospective study was carried out, examining resected hemimandibular specimens in 
patients diagnosed with solid and multicystic ameloblastoma over a one year period [2010 – 
2011].  All patients were treated at the Charlotte Maxeke Johannesburg Academic and the 
Chris Hani Baragwanath Hospitals, Johannesburg, South Africa.  The current treatment 
standard for this type of ameloblastoma is resection of the involved mandible, including 
removal of the associated inferior alveolar nerve.  Thus there was no change to the current 
accepted treatment protocol for patients with solid and multicystic ameloblastoma in the 
Division of Oral and Maxillofacial Surgery at the University of the Witwatersrand. 
 
4.2 Study sample 
Following routine surgical treatment of patients with solid and multicystic ameloblastomas, 
13 resected hemimandibulectomy specimens, which included the inferior alveolar canal, were 
microscopically examined.  The course of the inferior alveolar canal and nerve as well as 
tumour association to the inferior alveolar canal were imaged and studied using plain film 
radiographs prior to serial sectioning of the resected specimen.  This was done only as a 
guide to locate the histologic pathway of the nerve.  The specimens were divided into 2 
groups as outlined below, with 8 patients in the first group and 5 patients in the second group.   
 Group 1 included cases where the portion of the mandible containing the tumour was 
resected leaving the inferior alveolar nerve in position, and thus allowing an in situ 
histological examination of the nerve and tumour (Figs. 4.1 and 4.2).  The closest 
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distance between the neurovascular bundle (epineurium) and the tumour cells were 
measured.  The canal was examined to determine whether it was merely displaced or 
whether there was any erosion by the tumour, on those portions of the canal that were 
present on the serial sections examined.  The closest distance between the 
neurovascular bundle (epineurium) and the tumour cells were measured.   
 Group 2 comprised of the resected mandibular specimens in which the investigator 
mimicked the surgical pull-through technique as described by Ishikawa et al.
5
 on the 
unfixed specimen, immediately after resection in theatre, prior to submission in 
formalin for histopathological examination.  The nerve and the tumour were examined 
separately (Figs 4.3, 4.4 and 4.5).  The presence or absence of tumour cells in or on 
the nerve was evaluated.  In the ameloblastoma specimen, the closest distance 
between tumour cells and the inferior alveolar canal (devoid of the explanted nerve) 
was measured. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.1 Group 1: patient with a solid and multicystic ameloblastoma of the right body, symphysis,       
left angle and body of mandible 
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Fig 4.2 Group 1: mandibulectomy specimen of the solid and multicystic ameloblastoma from  
patient in Fig 4.1 above 
 
 
Fig 4.3 Group 2: inferior alveolar nerve from the hemimandibulectomy specimen, which was 
pulled out of the tumour immediately after resection.  The proximal end of the nerve is marked  
with suturing material 
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Fig 4.4 Group 2: resected hemimandibulectomy specimen prior to removal of the inferior alveolar  
nerve  
 
Fig. 4.5 Group 2: resected hemimandibulectomy specimen after removal of the inferior alveolar 
nerve; note the violation of the tumour on the distobuccal aspect due to difficulty in removing 
the nerve 
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4.3 Method 
Following fixation in 10% neutral buffered formalin (18-48 hours) and decalcification in 
hydrochloric acid/formic acid working solution (EDTA) 20 times the specimen volume, the 
mandibular resection specimens were serially sectioned and then routinely processed and 
embedded in paraffin wax.  Only the bone specimens were decalcified, and whilst the 
separate segments of pulled-through inferior alveolar nerve were not decalcified, they were 
subjected to a similar preparation technique.  The orientation and serial sectioning of the 
gross resection specimen was done by the investigator under the supervision and guidance of 
a trainee histopathologist in the Division of Oral Pathology.  
 
The portion of the mandibular bone containing the inferior alveolar canal, as determined on 
pre-operative CT scan, post-operative plain film radiographs and macroscopic orientation of 
the specimen, was serially sectioned into 10mm blocks using a band saw.  These blocks were 
sequentially numbered, to facilitate correlation with the radiographs.  Radiographic 
examination of the specimen was purely to determine the path of the inferior alveolar nerve, 
and radiographic data did not form an integral part of the study.  4µm haematoxylin and eosin 
(H&E) stained histological sections were reviewed by the principal investigator in 
conjunction with an oral histopathologist using a dual headed conventional light microscope 
[Nikon Eclipse 80i (Nikon Corp, Tokyo, Japan)] fitted with 10x oculars and a 40x objective 
for specific measurement of the distance between the ameloblastoma cells and the inferior 
alveolar nerve histologically. 
  
24 
 
 
 
 
Fig. 4.6 Group 1: plain film radiograph of a resected hemimandibulectomy specimen; note the 
loss of continuity of the inferior alveolar canal (arrows) 
 
4.4 Evaluation 
The deparaffinised 4ųm H&E histological sections of both Groups 1 and 2 were examined to 
evaluate the presence and proximity of ameloblastoma cells to the inferior alveolar nerve, 
more specifically examining whether any tumour cells remained attached to and were 
removed with the nerve, as well as to examine the corresponding portion of the canal within 
the tumour to correlate the proximity of the cells to the canal and the inferior alveolar nerve.    
 
In Group 1, where the nerve was examined in situ, the closest distance between the main 
nerve (epineurium) and the tumour was measured.  The presence of intra-neural tumour 
deposition was recorded.  Furthermore, the histological variants of ameloblastoma were 
documented in view of the possibility that certain histological variants being more likely to 
infiltrate the nerve bundle.  The proximity of the tumour cells to the nerve were measured 
histologically in millimetres and the measurements of the closest distance between tumour 
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and nerve were measured independently by 2 histopathologists.  The closest distance of 
ameloblastomatous cells to the inferior alveolar nerve for each case was recorded. 
 
For cases in Group 2, the nerve was examined independently of the tumour but in a similar 
manner.  The presence or absence of tumour cells within isolated inferior alveolar nerve was 
noted.  The closest distance of ameloblastoma tumour cells to the inferior alveolar canal was 
measured in the hemimandibulectomy specimen and recorded.  The data for both Groups 1 
and 2 were recorded on data sheets and statistically analysed. 
 
4.5 Ethical considerations 
An ethics clearance certificate specific for this project (No: M10555) was obtained from the 
Human Research Ethics Committee (Medical) of the University of the Witwatersrand for the 
use of the patient specimens needed for this study (Appendix 1).  The identities of the 
patients were kept confidential.  Furthermore, the ethics code M080850 used for this research 
adheres to international ethical criteria for research.  This is a blanket code for use on archival 
block material obtained from human tissues allocated to the Division of Oral Pathology, 
Department of Anatomical Pathology and covers the review of the histological sections.   
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CHAPTER 5 
 
5.0 RESULTS 
 
5.1 Inter-observer reliability  
The measurements obtained by two different observers at two separate occasions were 
compared with each other using the paired sample t-test for parametric data.  There was no 
statistically significant difference between the means of the two variables; p = 0.1168. 
 
5.2 Clinicopathologic data results 
The study population consisted of 13 patients in total, with 8 patients in Group 1 and 5 
patients in Group 2.  The demographic data of the patients in Groups 1 and 2 are listed in 
Table 5.1.  Of the study population, 46.2% were male and 53.8% female.  African blacks 
accounted for 92.3% of the study population. 
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Table 5.1 Study population demographics 
 Age Sex Race 
Patient 1 35 M African 
Patient 2 17 F African 
Patient 3 19 F African 
Patient 4 51 M African 
Patient 5 61 F African 
Patient 6 49 F African 
Patient 7 61 M African 
Patient 8 57 M Caucasian 
Patient 9 18 M African 
Patient 10 14 F African 
Patient 11 29 M African 
Patient 12 27 F African 
Patient 13 37 F African 
 
5.3 The histologic association of ameloblastoma cells to the inferior alveolar nerve 
5.3.1 Histologic association of ameloblastoma to inferior alveolar nerve in situ 
Perineural and intraneural ameloblastoma in the form of either direct involvement (Fig. 5.1) 
or apposition of tumour cells to the inferior alveolar nerve (Fig. 5.2) respectively, was noted 
in 5 of the 8 patients in Group 1 (62.5%), irrespective of the histological variant of 
ameloblastoma (Table 5.2).  Intraneural tumour deposition was present in 2 of the 8 patients 
(25%) and ameloblastoma tumour cells were noted abutting directly onto the nerve in 3 cases 
(37.5%).  The average closest distance between ameloblastoma cells and the inferior alveolar 
nerve in specimens taken from the patients in Group 1 was 0.437mm.   
 
The histological variants in these 5 cases comprised follicular, plexiform, granular, adenoid 
and basaloid ameloblastomatous patterns.  In this study, 10 of the 13 solid and multicystic 
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ameloblastomas (76.9%) showed mixed histological growth patterns, with the follicular and 
plexiform patterns predominating.  Irrespective of the histological variant of the 
ameloblastoma, 7 of the 13 cases (53.8%) showed neural involvement by the ameloblastoma.  
Thus there appears to be no correlation between the histological subtypes of the tumour and 
the proximity of tumour cells to the nerve.      
 
 Table 5.2 Histological association of ameloblastoma to inferior alveolar nerve in patients in Group 1 
Case Histologic variant Proximity of closest tumour 
cells to nerve (mm) 
Presence of intraneural/ 
perineural tumour 
Patient 1 Plexiform, Granular 0.25 No 
Patient 2 Follicular, Plexiform 0.25 Tumour abutting onto nerve  
Patient 3 
 
Follicular, Plexiform, 
Adenoid  
0 Yes  
Patient 4 Follicular 1 No 
Patient 5 Follicular, Basaloid 1.5 No 
Patient 6 Plexiform, Granular  0.25 Tumour abutting onto nerve  
Patient 7 Follicular, Plexiform 0 Yes  
Patient 8  Basaloid 0.25 Tumour abutting onto nerve  
 
In cases of intraneural tumour involvement, ameloblastoma follicles were noted permeating 
the epineurium (Fig. 5.1).  One case of perineural involvement showed the nerve to be 
sheathed by plexiform and follicular arrangements of ameloblastoma (Fig. 5.3).  
Immunohistochemical staining in the presence of adequate preparations and controls was 
performed where necessary to confirm the presence of the inferior alveolar nerve with S-100 
protein (Dako, Glostrup, Denmark) (Figs. 5.4 and 5.5) and the islands of ameloblastoma with 
calretinin (Dako, Glostrup, Denmark).  
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In some cases, even though there was no direct intraneural or perineural involvement of the 
inferior alveolar nerve by ameloblastoma, tumour was noted in close proximity to  
the nerve (Fig. 5.6).  Some tumours were separated from the inferior alveolar nerve by a shelf 
of bone (Fig. 5.7), whilst in other cases the mandibular bone encasing the inferior alveolar 
bone was totally destroyed allowing infiltration of the ameloblastoma islands and subsequent 
abutment of tumour onto the inferior alveolar nerve (Figs. 5.2 and 5.3).  Other cases showed 
separation of ameloblastoma from the nerve only by a few strands of collagenous fibrous 
connective tissue with no intervening bone (Fig. 5.6).  In yet another case, the inferior 
alveolar nerve was noted “dipping” into and between the ameloblastoma (Fig. 5.8). 
 
Fig. 5.1 Ameloblastic follicles (AF - small arrow) within the epineurium (E) of the inferior  
alveolar nerve (IAN); solid ameloblastoma (A) abutting onto the perineurium (P) of the IAN  
(large arrow) (H&E stained section of case 8 (Group1), x400 original magnification) 
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Fig. 5.2 Solid and multicystic ameloblastoma (A) noted abutting directly onto the epineurium                        
of the inferior alveolar nerve (IAN) which is partially encased by the mandibular bone (B).  The 
ameloblastoma exhibits both a follicular and plexiform growth pattern (H&E stained section of  
Case 8 (Group1), x40 original magnification) 
 
 
Fig. 5.3 Plexiform and follicular solid and multicystic ameloblastoma (A) enveloping and                     
abutting directly onto the epineurium of the inferior alveolar nerve (IAN) (arrows) (H&E                       
stained section of Case 8 (Group1), x200 original magnification) 
31 
 
 
 
 
Fig 5.4 Solid and multicystic ameloblastoma (A) conjoined to the perineurium of the inferior  
alveolar nerve (IAN), which is highlighted by the brown immunopositivity with S-100 protein 
(A) (arrows) (S-100 immunostained section of Case 8 (Group1), x40 original magnification) 
 
Fig. 5.5 S-100 immunostain highlights the inferior alveolar nerve (IAN) which is in close  
proximity to the ameloblastoma (A), separated from the tumour  only by fibrous connective tissue 
with no bone barrier (S-100 protein immunostained section of Case 8 (Group1), x100 original 
magnification) 
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Fig. 5.6 The inferior alveolar nerve (IAN) which is in close proximity to the ameloblastoma (A),    
separated from the tumour by fibrous connective tissue (F) with no bone barrier. (H&E stained 
section of Case 1 (Group1), x100 original magnification) 
 
 
Fig. 5.7 The inferior alveolar nerve (IAN) is separated from the ameloblastoma (A), by fibrous  
connective tissue (F) and a bone barrier (B). (H&E stained section of Case 3 (Group1), x40 
 original magnification) 
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Fig. 5.8 Ameloblastoma (A) noted “dipping” into the nerve (IAN); the nerve appears divided by 
 tumour (dotted line) (H&E stained section of Case 3 (Group1), x100 original magnification)  
 
 
Fig. 5.9 Islands of ameloblastomatous tumour (A) noted within the nerve bundle of the pulled              
out inferior alveolar nerve (IAN) (H&E stained section of Case 13 (Group2), x40 original  
magnification) 
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Fig. 5.10 An island of active odontogenic epithelium (encircled) noted within the inferior  
alveolar nerve bundle (IAN) (H&E stained section of Case 11 (Group2), x200 original 
magnification) 
 
5.3.2 Histologic association of ameloblastoma to the pulled through inferior alveolar 
nerve and the inferior alveolar canal 
As for Group 1, there was perineural and intraneural ameloblastoma cells in and around the 
inferior alveolar nerve and canal (Table 5.3 and Figs. 5.9 and 5.10 respectively).  Intraneural 
ameloblastoma was evident in 2 of the 5 patients in Group 2 (40%), irrespective of the 
histological variant of ameloblastoma (Table 5.2).  In 2 of the 5 cases (40%) no canal could 
be identified in close proximity to the nerve, both radiographically and histologically.  
Similar to Group 1, there was no correlation between the histological variants of 
ameloblastoma and the presence of tumour within the pulled-out nerve bundle.   
 
The raw data for both Groups 1 and 2 are presented in Appendices 2 and 3. 
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Table 5.3 Histological association of ameloblastoma to inferior alveolar nerve in patients in Group 2 
Case Histological 
variant 
Presence of tumour cells in 
pulled out nerve 
Distance of tumour cells to 
nerve canal (mm) 
Patient 9 Plexiform No No canal identified in relation 
to tumour 
Patient 10 Follicular, 
Plexiform 
No No canal identified in relation 
to tumour 
Patient 11 
 
Follicular, 
Plexiform 
Yes  0.5 
Patient 12 
 
Plexiform, 
Granular cell 
No 1 
Patient 13 
 
Plexiform 
[Recurrence] 
Yes  0,3 
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CHAPTER 6 
 
6.0 DISCUSSION 
 
6.1 Statement of the principal findings 
This study confirmed neural involvement in 53.8% of cases of mandibular ameloblastomas in 
which the inferior alveolar nerve was removed together with the resected mandibular 
specimen as well as when pulled through separately from the mandibular resection specimen. 
 
In this study, in order to validate a surgical procedure advocated by some surgeons,
5,11
 the 
surgical technique of pulling the inferior alveolar nerve out of the ameloblastoma at the time 
of resection was mimicked and the association between the nerve and tumour histologically 
examined.  A totally unexpected finding was that of peri- and intraneural involvement of the 
inferior alveolar nerve in the mandibular ameloblastoma since cells from a benign tumour 
generally do not show neural infiltration. 
 
As expected of most benign tumours, a clear demarcation or delineation between the 
ameloblastoma tumour cells and the unaffected inferior alveolar nerve bundle was 
anticipated.  Even though ameloblastomas are locally aggressive and often reach very large 
proportions with displacement and erosion of local structures, there is still a distinct 
demarcation in most cases between the tumour and the nerve.  Perineural invasion is not 
characteristic of benign lesions.   
  
This study demonstrated the presence of ameloblastoma tumour cells not only in very close 
proximity to the inferior alveolar nerve bundle, but also within the nerve itself.  In addition to 
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actual ameloblastoma tumour cells, benign odontogenic epithelial cell rests within the inferior 
alveolar nerve canal was also an unexpected finding.  This however cannot be ignored, 
bearing in mind that ameloblastomas can arise within odontogenic epithelial cell rests.  Even 
though these odontogenic cell rests were inactive and showed no features of 
ameloblastomatous differentiation, there is a high probability of recurrent or de novo 
ameloblastoma arising within this satellite or daughter island at some stage following 
differentiation should the nerve be spared.  There is absolutely no way to determine or predict 
exactly how these aberrant cell rests will behave. 
 
Exactly why the ameloblastoma is noted infiltrating or “dipping” into the nerve, is not 
known.  It can however be postulated that the nerve is slowly splayed by the pressure from 
the expanding tumour, especially if the inferior alveolar canal has already been eroded.  Our 
hypothesis is that following an incisional biopsy to confirm the diagnosis of ameloblastoma, 
and decompression of the lesion, the release of pressure allows the nerve some freedom of 
movement, and in an attempt to regain its original shape, it recoils and closes up around the 
tumour entrapping tumour islands.  Another possible explanation is that the section viewed is 
through a U-loop of the nerve, either towards or away from the viewer, caused by a tumour 
locule.  The presence of this “dipping effect” of the tumour with ameloblastoma present in 
between the nerve bundle and flanked on either side by inferior alveolar nerve poses a further 
threat in the management of these lesions as there is no guarantee that the nerve, when being 
pulled out, would not pull along or seed the tumour cells that are noted “dipping” into it.   
This finding shows that the recommendation by Nakamura et al.
11
 to first shrink the tumour 
by means of marsupialisation,
 
followed by pull-through of the nerve upon resection is not a 
safe or viable treatment option.  Marsupialisation results in decompression and the nerve may 
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very well recoil and “pinch” the tumour with resultant tumour tissue being removed together 
with the nerve. 
 
Gortzak et al.
12
 and Slootweg et al.
15
 stated that if there are signs of bone breakthrough, the 
dissection should be extended to the next tumour free tissue plane.  This raises the question as 
to whether the epifascicular plain is an adequately safe plain for dissection (as described by 
Tung-Yiu et al.
34
) as odontogenic epithelium was clearly demonstrated within the inferior 
alveolar nerve in the present study.  Thus, the absence of a clear plane necessitates removal of 
the nerve. 
 
The surgical treatment planning of a mandibular ameloblastoma necessitates not only 
delineation of the full extent of the tumour within bone and soft tissue, following cortical 
bone perforation, but also consideration of the management of the inferior alveolar nerve 
bundle.  Any residual tumour within the nerve bundle may be a source of recurrence 
following conservative management.
14
  Wide resection is the recommended and accepted 
treatment protocol for mandibular solid and multicystic ameloblastomas.
4
  This however 
results in the sacrifice of the inferior alveolar nerve which results in permanent numbness of 
the region innervated by the mental nerve.  It is with this in mind that authors
5,6,11
 have 
recommended avoidance of resection of the nerve.   
 
Based on the findings of their study which showed no invasion of the nerve or nerve sheath 
by ameloblastoma, Nakamura et al.
11
 recommended that a more conservative approach and 
proper follow up is acceptable if the canal wall is not destroyed.  Ishikawa et al.
5
 reported a 
method to preserve the inferior alveolar nerve when the wall of the bony canal is intact.  
However, Nakamura et al.
11
 found that even when the bony wall of the mandibular canal was 
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destroyed the ameloblastoma was clearly separated from the nerve by bone or connective 
tissue.  This certainly was not the case in the current study where there was at least 53.8% 
neural involvement by ameloblastoma.  
 
Whilst computed tomography may give an indication as to the relationship between the 
tumour and the inferior alveolar nerve, definitive confirmation of tumour in and around the 
nerve and micro-destruction of the inferior alveolar canal can only be done histologically.  In 
the present study it was apparent that it is impossible to confirm neural or mandibular canal 
involvement via radiographs and in tissue taken from an incisional biopsy.  Moreover, 
involvement of the nerve and canal by tumour is only evident on serial sectioning of the 
entire resected mandibular specimen.  It is not standard practice to serial section the entire 
tumour after resection has been carried out.  Normal protocol dictates that the mucosal, soft 
tissue and bone, surgical margins are checked for tumour clearance and random sections for 
confirmation of tumour and subtype.  
  
In a review of treatment modalities, Pogrel et al
4
 conclude that surgical resection of the solid 
and multicystic ameloblastoma should be aggressive.  One of the main reasons for this is the 
high recurrence rate and unpredictability of the tumour’s biologic behaviour.  Pourian et al.14 
also reported that tumour adjacent to or within the mandibular canal may destroy and grow 
into the canal, involving the epineurium and ultimately the nerve itself.  In this regard, an 
aggressive treatment approach to the management of the nerve should be maintained.  In 
determining the possible surgical approach to the treatment of the mandibular ameloblastoma, 
there is no doubt that prevention of a recurrence in the patient far outweighs the limited 
morbidity of permanent numbness in the area of innervation. 
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Nakamura et al.
11
 advocated that histological variant is important in determining the 
biological behaviour of the ameloblastoma, and that the growth characteristics of the tumour 
must be considered in the surgical treatment planning of solid and multicystic 
ameloblastomas.  Consequently they recommended a more conservative approach with 
meticulous follow up in ameloblastomas with a plexiform growth pattern, provided that there 
is no destruction of the canal wall.  Most ameloblastomas in our study (76.9%) showed a 
mixed histological growth pattern, however neural involvement by ameloblastoma occurred 
irrespective of the histologic variant.  Thus inferior alveolar nerve involvement was not 
dependent on the gross or histologic type of the ameloblastoma.  Furthermore, accurate 
histological sub-typing as well as the aggressive versus non-aggressive nature of the tumour 
cannot be made on an incisional biopsy as the tissue submitted may not be representative of 
the histologic type of the entire ameloblastoma. 
 
Whilst the nerve pull through technique has been promoted by Nakamura et al.,
11
 Wu et al.
6
 
and Ishikawa et al.
5
 we encountered technical difficulty with the surgical removal of the 
inferior alveolar nerve in patients of Group 2.  In contrast to the relative ease of this pull 
through surgical technique described by Ishikawa et al.,
5 
we found that it was extremely 
difficult to deliver the nerve from the tumour.  The inferior alveolar nerve could not be freed 
easily by pull and manipulation from the mental or mandibular foramina.  In fact, in 2 cases 
the tumour had to be cut open in order to deliver the nerve intact.  The technique is extremely 
difficult, and if done in situ, seeding of tumour cells is a distinct possibility.  Even in cases 
where the canal appeared well corticated on pre-operative radiographic views, the inferior 
alveolar nerve appeared to be well attached to the adjacent structures and proved to be 
extremely difficult to remove. 
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The treatment modality is the most important prognostic indicator for treatment to be curative 
in ameloblastomas.
4
  There is a likelihood of tumour recurrence, especially if the surgery is 
not aggressive.  As was noted, the nerve cannot always be reliably delivered free of tumour 
cells and hence, being conservative and sparing the inferior alveolar nerve in the treatment of 
ameloblastomas will be detrimental to the patient.  In all instances, the best chance at 
successful treatment will always remain the first chance. 
 
6.2 The strength and the weakness of the study 
The strength of the study is the histologic demonstration of tumour cells that have adhered to 
and infiltrated the inferior alveolar nerve.  Even though the sample size is small, evidence of 
neural involvement by ameloblastoma even in one case is sufficient to mitigate against the 
nerve pull through surgical technique as encouraged by Ishikawa et al.
5
  The evidence of 
neural involvement by ameloblastoma in this study is sufficient to show that there is no doubt 
that the proposed technique is unsafe and unfeasible, and would lead to recurrence of the 
tumour.  Ideally, more patients from each group need to be evaluated. 
 
6.3 The meaning of the study and surgical application 
This is a highly relevant and pertinent study as it forms the basis of a protocol for the 
effective surgical management of the mandibular solid and multicystic ameloblastoma. 
Maxillofacial and oral surgeons can be confidently guided in the treatment planning for 
patients with mandibular ameloblastoma by the findings in this study, in which there is sound 
evidence for the inferior alveolar nerve to be removed together with the ameloblastoma. 
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6.4 Future research 
A similar prospective study on a much larger cohort of patients will scientifically and 
statistically seal the findings of this study.  However, this cohort is sufficient to recommend 
that future research be focused on devising new methods to reinstate sensation in areas 
innervated by the inferior alveolar nerve, rather than investigating techniques to spare the 
nerve. 
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CHAPTER 7 
 
7.0 CONCLUSION 
 
Both peri- and intraneural involvement of the inferior alveolar nerve was histologically 
confirmed in solid and multicystic hemimandibular specimens both in situ within the tumour 
as well as in separately removed segments of the nerve. 
 
Preservation of the inferior alveolar nerve during ablative surgery for mandibular 
ameloblastomas cannot be advocated. 
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CHAPTER 8 
 
8.0 APENDICES 
 
8.1 APPENDIX 1: 
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8.2 APPENDIX 2: 
Individual patient slide descriptions 
   
1)       Patient 1 
A1: Granular plexiform variant tumour. Close proximity to nerve at 0.25mm (next to blue line)  
A2: Tumour in close proximity to nerve, at 0.25mm 
A3: Tumour noted 
A4: Tumour noted, margins clear 
A5: Tumour noted in soft tissue but margin clear. 
A6: Inferior alveolar canal noted, surrounded by bone and separated from tumour by bone 
A7: Slide missing 
A8: Granular plexiform pattern tumour, no nerve noted 
A9: Granular plexiform pattern tumour, no nerve noted 
A10: Inferior alveolar nerve less than 0.25mm away from tumour, break in bone continuity at canal, 
nerve is only separated from tumour by soft tissue 
A10: Tumour noted, no nerve 
A11: Nerve surrounded by bony chips interspersed with ameloblastomatous islands 
A12: Inferior alveolar nerve noted, tumour noted not too close proximity  (2mm) 
A13: Tumour noted, no nerve 
A14: Tumour noted, no nerve 
A15: Tumour separated from nerve by bone 
 
2)       Patient 2 
A1: Plexiform pattern tumour noted within bone, no nerve noted 
A2: Nerve encased by bone, but lingually there is bone destruction noted. In some areas there is no 
separation by bone of tumour and nerve. 0.5mm distance between bone and tumour.  
A3: Bone separating nerve and tumour. 0.75mm distance. See “Folded locule”: IAN and second 
nerve twig is not separated from tumour by bone, and is 0.25mm away. The cystic structure is 
large and folded over and very close to nerve twigs within the wall. 
 A4: No tumour or nerve noted 
 A5: No tumour or nerve noted 
 A6: No tumour or nerve noted  
 A7: No tumour noted, nerve seen 
 A8: Nerve surrounded by extensive marrow tissue. Tumour is quite a distance away. 
 A9: No tumour noted, nerve seen 
 A10: No tumour or nerve noted 
 A11: Nerve noted at the apex of the tooth, surrounded by marrow. 
 A12:  No tumour noted, nerve seen 
 A13: No tumour noted, nerve seen 
 A14: At the inferior border the nerve bundle is pushed away by tumour, and is sitting right up at  
the cortex, 0.5mm from the epithelial lining and 0.25mm from the wall of the Ameloblastoma.  
 A15: Slide missing 
 A16: Slide missing 
 A17:  Nerve twigs noted, no bundle or tumour seen 
 A18: Tumour noted 
 A19: Nerve is 0.25mm from the epithelial lining but abutting onto the tumour cyst wall 
 A20: Plexiform and follicular pattern 
 A21: Islands away from main tumour illustrates infiltrative nature of tumour. 
 A22: Tumour noted 
 A23: Nerve twigs in close proximity to tumour (0.25mm) 
 A24: Tumour noted 
 
3)    Patient 3 
A: Free mucosal margin 
B: Tumour noted, margin clear, no nerve seen 
C: Tumour noted, margin clear, no nerve seen 
D: Tumour noted, margin clear, no nerve seen 
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E: Tumour noted, margin clear, no nerve seen 
F: No tumour or nerve noted 
G: Tumour noted, margin clear, no nerve seen 
H: Tumour noted, margin clear, no nerve seen 
I: No tumour or nerve noted 
J: Tumour noted, margin clear, no nerve seen. Adenoid pattern 
K: Tumour noted, margin clear, no nerve seen. Plexiform pattern 
L: Tumour noted, margin clear, no nerve seen 
M: Tumour noted, margin clear, no nerve seen. Plexiform pattern 
N: No tumour noted. Medium sized nerve twigs seen 
O: Medium sized nerve twigs with muscle and vessels. Tumour present, but not involving  
nerves 
P: Medium sized nerve twigs with muscle and vessels. No tumour. 
Q: Nerves noted, no tumour 
R: Nerve separated from tumour by cortical bone 
S: Proliferative periosteal bone reaction noted. No nerve 
T: Nerve separated from tumour by cortical bone 
U: No nerve 
V: No nerve 
W: Nerve separated from tumour by cortical bone and muscle 
X: Tumour noted in between roots of teeth 
Y: No nerve 
Z: Small nerve seen close to epithelium, separated from tumour by a tooth 
AA: Tumour either side of bone and against tooth. 0.5mm away from tumour 
AB: Nerve “dipping into” tumour (S100)  
AC: Nerve 0.5mm away from tumour  
AD: Nerve separated from tumour by cortical bone 
AE: Tumour noted, no nerve seen 
AF: Nerve within marrow bone, no tumour 
AG: Slide missing 
AH: Nerve bundle separated from tumour by bone (2mm)  
AI: Nerve bundle separated from tumour by bone 
AJ: Tumour noted, no nerve seen 
AK: Nerve encased in bone, pushed aside by tumour 
AL: Tumour noted, no nerve seen 
AM: Nerve separated from tumour by bone 
AN: Nerve close to tumour cyst, no bone separating it, 0.5mm  
AO: Nerve encased in bone 
AP: Nerve on either side of tumour. Tumour dipping into bundle 
AQ: No nerve, Follicular mixed plexiform pattern 
AR: Nerve close to tumour 
AS: Tumour noted, no nerve seen 
AT: Nerve/smooth muscle next to cyst (S100) 
AU: Tumour noted, no nerve seen 
AV: Tumour noted, no nerve seen 
AW: Tumour noted, no nerve seen 
 
4)  Patient 4 
A: Clear mucosal margin 
B: Clear mucosal margin 
C: Clear mucosal margin 
D: Clear mucosal margin 
E: Clear mucosal margin 
F: Clear mucosal margin 
G: Clear mucosal margin 
H: Clear mucosal margin 
I: Clear mucosal margin 
J: Clear mucosal margin 
K:  Clear soft tissue margin 
L: Clear soft tissue margin 
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M: Tumour very infiltrative, small follicles very spread out. No nerve seen. 
N: Tumour noted, no nerve seen 
O:  Nerve separated from tumour by bone, tumour “chomping up” bone. 1mm  
P: Tumour noted, no nerve seen 
Q: Tumour noted, no nerve seen 
R: Nerve encased in bone 
S: Tumour noted, no nerve seen 
T: Tumour noted, no nerve seen 
U: Tumour noted, no nerve seen 
V: Tumour noted, no nerve seen 
W: Tumour noted, no nerve seen 
X: Nerve separated from tumour by bone 
Y: Nerve noted, no tumour seen 
Z: Tumour noted, no nerve seen 
AA: No nerve or tumour seen 
AB: Nerve seen, tumour far removed 
AC: No nerve or tumour seen 
AD:  No nerve or tumour seen 
 
5.     Patient 5 
A11: Nerve noted, away from tumour 
A12: Nerve separated from tumour by bone 
A21: Nerve separated from tumour by bone. Follicular basaloid appearance 
A22: Nerve separated from tumour by bone. Very solid tumour 
A3: Nerve separated from tumour by bone 
A4: Nerve separated from tumour by bone. Basal cell variant 
A51: Tumour noted no nerve seen 
A52: Tumour noted no nerve seen 
A61: Tumour noted no nerve seen 
A62: Tumour noted no nerve seen 
A71: Tumour noted no nerve seen 
A72: Tumour noted no nerve seen, Very infiltrative 
A81: Nerve separated from tumour by inflammatory connective tissue, 1.5mm  
A82: Nerve separated from tumour by inflammatory connective tissue, 1.5mm 
A91: Tumour noted no nerve seen 
A92: Tumour noted no nerve seen 
A10: No tumour or nerve seen 
A11: No nerve seen 
 
6.    Patient 6  
A: Clear mucosal margin 
B: Clear mucosal margin 
C: Clear mucosal margin 
D: Tumour with overlying epithelium 
E: Tumour with overlying epithelium 
F: Tumour noted no nerve seen 
G: Soft tissue 
H: Clear mucosal margin 
I: Tumour in soft tissue, solid. No nerve 
J: Plexiform granular cell variant, no nerve seen 
K: Tumour noted no nerve seen 
L: Tumour noted no nerve seen 
M: Tumour noted no nerve seen 
N: Tumour noted no nerve seen 
O: Tumour noted no nerve seen 
P: No nerve or tumour noted 
Q: Tumour noted no nerve seen 
R: Tumour noted no nerve seen 
S: Tumour noted no nerve seen 
T: Tumour noted no nerve seen 
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U: Tumour noted no nerve seen 
V: Tumour noted no nerve seen 
W: Tumour noted no nerve seen 
X: Tumour noted no nerve seen 
Y: Tumour noted no nerve seen 
Z: Nerve very close to tumour, 0.25mm away, separated only by fibrous connective tissue  
wall of tumour  
AA: Infiltrative pattern noted, no nerve seen 
AB: Tumour noted no nerve seen 
AC: Nerve seen far away from tumour 
AD: Tumour noted no nerve seen 
AE: Inflammatory cells seen, suppuration noted 
 
7.    Patient 7 
 A: Clear mucosal margin 
 B: Clear mucosal margin 
 C: Clear mucosal margin 
 D: Clear mucosal margin 
 E: Clear mucosal margin 
 F: Clear mucosal margin 
 G: No tumour or nerve noted 
 H: No tumour or nerve noted 
 I: Nerve separated from tumour by fibrous connective tissue, 1mm 
 J: Tumour noted no nerve seen 
 K: Tumour noted no nerve seen 
 L: Tumour noted no nerve seen. Plexiform and follicular pattern 
 M: Tumour noted no nerve seen 
 N: Nerve twig separated from tumour cyst by fibrous connective tissue, 1mm 
 O: Nerve twig separated from tumour cyst by fibrous connective tissue, 1mm 
 P: Tumour noted no nerve seen 
 Q: Looks like nerve close to tumour (S100 ordered). Tumour within nerve at a different  
section on slide 
 R: Tumour noted no nerve seen 
 S: Tumour noted, small nerve twigs noted far away 
 T: Clear 
 U: Nerve separated from tumour by fibrous connective tissue 
 
8.   Patient 8 
 A: No tumour or nerve seen 
 Ax: Tumour noted no nerve seen 
 B: Tumour noted no nerve seen 
 C: No tumour or nerve seen 
 D: Tumour noted no nerve seen 
DMC: Tumour abutting onto nerve, fibrous connective tissue wall of tumour on nerve. 0.25mm from 
ameloblastomatous epithelium  
E: Tumour noted no nerve seen 
 F: Tumour noted no nerve seen 
 G: Lots of basilar cells seen, little stellate reticulum, very solid, no nerve 
 GMC: No nerve seen 
 H: Tumour within soft tissue 
 HMC: No nerve seen 
 I: No nerve seen 
 J: No nerve seen 
 K: Nerve separated from tumour by bone, separate bundle abutting onto tumour 
 L: Nerve torn away from tissue 
 LMNF: poor stain 
 LS100: Nerve stained nicely but free lying 
 M: Tumour wall abutting onto tumour 
 Mx: Stain didn’t work due to decal 
 N: Nerve onto tumour 
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 NX: Nerve onto tumour 
 O: Tumour wall abutting onto nerve 
 P: No nerve seen 
 Q: Tumour noted no nerve seen 
 QX: Tumour noted no nerve seen 
 R: No tumour seen 
 S: No tumour seen 
 
9.             Patient 9 
Nerve: 
A – D: (slides of nerve) Clear. Nerve only, no tumour seen. Areas of fibrous  
 connective tissue show inflammation 
 
Tumour: 
E: Right Post bony resection margin, Clear. 
F: Right Post bony resection margin, Clear. Nerve seen, but no tumour. Nerve totally encased by 
host bone, no evidence of tumour in vicinity. Tumour noted on surface of impacted tooth, but 
separated from nerve. 
G: Left bony resection margin, Clear. 
H: Clear  
I: Clear  
J: Tumour seen, no nerve noted. Plexiform variant 
K:  Tumour seen, no nerve noted. 
L: Clear 
M: Clear  
N: Clear  
O: Clear  
P: Small nerve noted in bone, no tumour seen, posterior margin 
Q: Clear  
 
10. Patient 10 
A: Lymph node 
A1 – A2 and stained slide p24: Reactive lymphoid hyperplasia in keeping with chronic antigenic  
stimulation. P24 is negative. No evidence of a neoplastic infiltrate in any of the sections  
examined. 
 
B: Nerve  
B1 – B16: Nerve. No evidence of tumour or odontogenic cell rests Evidence of retained suture  
     material on slide. 
 
C: Tumour 
C1: Muco-gingival margin clear 
C2: Muco-gingival margin clear 
C3: Muco-gingival margin clear, Inflammation noted 
C4: Muco-gingival margin clear 
C5: Muco-gingival margin clear 
C6: Muco-gingival margin clear, Tumour in submucosa 
C7: Muco-gingival margin clear 
C8: Muco-gingival margin clear 
C9: Muco-gingival margin clear 
C10: Muco-gingival margin clear 
C11: Muco-gingival margin clear 
C12: Muco-gingival margin clear 
C13: Muco-gingival margin clear, bacteria noted 
C14: Muco-gingival margin clear 
C15: Muco-gingival margin clear 
C16: Muco-gingival margin clear 
C18: Muco-gingival margin clear 
C19: Soft tissue margin close to tumour 
C20: Solid and plexiform variant of tumour. Tumour close to soft tissue resection margin, but  
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clear. Carry-over noted 
C21:  Tumour close to margin, but clear 
C22: Tumour close to margin, but clear 
C23: Tumour close to margin, but clear 
C24:  Soft tissue, clear 
C25: Soft tissue, clear 
C26:  Tumour close to margin, but clear 
C27: Soft tissue, clear 
C28: Soft tissue, clear 
C29: Soft tissue, clear 
C30: Tumour close to margin, but clear 
C31: Soft tissue, clear 
C32: Soft tissue, clear 
C33: Tumour, follicular and plexiform, no nerve noted 
C34: Tumour, follicular and plexiform, no nerve noted 
C35: Clear 
C36: Clear 
 
11.   Patient 11 
A: Tumour 
A1: No tumour 
A2: No tumour 
A3: No tumour 
A4: No tumour 
A5: Plexiform pattern, close to margin but clear 
A6: No tumour 
A7: No tumour 
A8: No tumour 
A9: Plexiform and Follicular pattern. Stroma showing desmoplasia, very close to sublingual  
gland. 
A10: Small follicles displaying distinctive ameloblastomatous features (reverse polarisation,  
infranuclear vacuolisation, subepithelial  
hyalinisation). Variable size diameter of follicles from 0.25mm to 2mm. Active and  
relatively far removed from larger tumour mass and cysts. 1mm away from largest tumour 
and 0.5mm away from nerve twig. Thus, in addition to the pulled out nerve there is  
accessory nerve supply in the area that is as close as 0.5mm to tumour. 
A11: Tumour close to margin but clear 
 A12: Small follicles away from main tumour 
 A13: No tumour, tooth within bone noted 
 
B: Nerve  
B1: Clear 
B2: Clear (lots of blood vessels) 
B3: Clear 
B4: Clear 
B5: Clear 
B6: Clear, Mast cells noted 
B7: Inactive odontogenic cell rests noted. Has not developed all the features of an 
 ameloblastoma, but can possibly cause recurrence. Cell rests not generally seen within  
tumour. 
B8: Clear 
B9: Clear 
B10: Clear 
 
12.  Patient 12 
A: Tumour 
A1: Clear 
A2: Clear 
A3: Clear 
A4: Tumour noted, no nerve seen 
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A5: Clear 
A6: Clear 
A7: Tumour noted, Plexiform Granular cell variant 
A8: Nerve twigs in anterior region – incisive lingual branches – clear of tumour  
A9: Clear 
A10: Clear 
A11: Clear 
A12: Clear 
A13: Clear 
A14: Large nerve buccally, not affected by tumour, there is tumour medial to nerve, but separating 
tumour is cortical bone and fibrous connective tissue wall. Tumour cells 1mm away from 
nerve. 
A15:  Clear 
A16: Clear 
A17: Clear 
A18: Tumour noted, no nerve seen 
A19: Clear 
A20: Clear 
A21: Tumour noted, no nerve seen 
A22: Tumour noted, no nerve seen 
A23: Tumour noted, no nerve seen 
A24: Tumour noted, no nerve seen 
A25: Tumour noted, no nerve seen 
A26: Tumour noted, no nerve seen 
A27: Tumour noted, no nerve seen 
 
B: Nerve 
B1 – B10: Nerve seen, no tumour noted on any slides 
B11: Inflammation noted with giant cells around nerve, no tumour noted 
B12: Clear with carry over noted on slide 
B13: Clear, nerve only 
B14: Cleat, nerve only 
 
13.    Patient 13 
A: Tumour noted 
A1: No tumour 
A2: No tumour 
A3: Plexiform pattern, margins clear 
A4: No tumour 
A5: Tumour noted, margins clear 
A6: No tumour 
A7: Tumour noted, margins clear 
A8: No tumour 
A9: Plexiform pattern, margins clear 
A10: Plexiform pattern, margins clear 
A11: Nerve twigs noted close to tumour (shows proximity to tumour) 1mm 
A12: No tumour 
A13: No tumour 
A14: No tumour 
A15: Tumour noted, margins clear 
A16: Tumour noted, margins clear 
A17: Tumour noted, margins clear 
A18: Tumour noted, margins clear 
A19: Tumour noted, margins clear 
A20: Tumour noted. Although the nerve was pulled through in this specimen, there are numerous 
smaller accessory nerves present. Here they are not involved by tumour. 
 B: Nerve 
 B1: No tumour 
 B2: No tumour 
 B3: No tumour 
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 B4: No tumour 
 B5: No tumour 
 B6: No tumour 
 B7: No tumour 
 B8: No tumour 
 B9: 3 levels reviewed: tumour cells noted 
 B10: Tumour noted within the inferior alveolar canal, pulled out with the nerve (tumour in soft  
tissue attached to nerve) (not carry over)  
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8.3 APPENDIX 3: 
Second observer measurements 
Closest distances between ameloblastomatous epithelium and nerve bundles 
1. Patient 1 (F) - tumour not identified. 
2. Patient 11 (A10) – 0,25mm from closest nerve twig. 
3. Patient 12 (A14) – 1mm from large nerve. 
4. Patient 13 (A11) – 1mm. 
5. Patient 13 (B10) – 0mm.  
6. Patient 1 (A1) – 0.25mm. 
7. Patient 1 (A2) – 0,25mm. 
8. Patient 1 (A10) – 0,25mm. 
9. Patient 1 (A12) – 1,1mm from smaller nerve twig and 2mm from large nerve in 
neurovascular bundle. 
10. Patient 2 (A2) – 0,5mm. 
11. Patient 2 (A3) – 0,7mm. 
12. Patient 2 (A14) – 0,5mm. 
13. Patient 2 (A19) – 0,25mm. 
14. Patient 2 (A23) – 0,25mm. 
15. Patient 3 (AA) – 0,5mm. 
16. Patient 3 (AC) – 0,5mm. 
17. Patient 3 (AH) – 2mm. 
18. Patient 3 (AN) – 0,5mm. 
19. Patient 4 (O) – 1mm. 
20. Patient 5 (A8) – 1,3mm. 
21. Patient 6 (Z) – 0,25mm. 
22. Patient 7 (I) – 1mm. 
23. Patient 8 (D) – 0,25mm. 
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